Health Care Provider Perspectives on Barriers and Facilitators to Tuberculosis Testing and Treatment in New York City

Author(s):  
M. Oluya ◽  
J. Zelnick ◽  
S. Rao
2016 ◽  
Vol 20 (12) ◽  
pp. 1625-1632 ◽  
Author(s):  
J. R. Zelnick ◽  
M. R. O'Donnell ◽  
S. D. Ahuja ◽  
A. Chua ◽  
J. Sullivan Meissner

Cancer ◽  
2021 ◽  
Author(s):  
Chen Fu ◽  
James H. Stoeckle ◽  
Lena Masri ◽  
Abhishek Pandey ◽  
Meng Cao ◽  
...  

2018 ◽  
Vol 53 (5) ◽  
pp. 3437-3454 ◽  
Author(s):  
Sungwoo Lim ◽  
Tejinder P. Singh ◽  
Gerod Hall ◽  
Sarah Walters ◽  
L. Hannah Gould

PEDIATRICS ◽  
1994 ◽  
Vol 93 (2) ◽  
pp. A38-A38
Author(s):  
J. F. L.

The Health Security Bill spells out the troubling answer. A National Health Board—seven people appointed by the president—will decide how much the nation can spend on health care each year. Based on that budget, the board puts price caps on premiums to limit the money paid into the health care system (pages 252, 974-977). If medical needs exceed that budget and premium money runs low, the bill requires state governments and insurers to make "automatic, mandatory, nondiscretionary reductions in payments" to doctors, nurses and hospitals are slashed, as the bill requires? New York City hospitals, which operate with only four days' cash on hand, would experience life-threatening shortages: nurses working without pay, medications withheld because of cost.


2011 ◽  
Vol 3 ◽  
pp. JCNSD.S4091 ◽  
Author(s):  
Heidi J. Wehring ◽  
Sheryl Thedford ◽  
Maju Koola ◽  
Deanna L. Kelly

Olanzapine long acting injection has joined risperidone and paliperidone as the second generation long acting antipsychotic injection options for treatment of patients with schizophrenia. Long acting injections are important alternatives to oral medications for patients who have difficulty adhering to daily or multiple daily medication administrations, yet may be underutilized or not well understood. Patient perceptions, adherence, and preferences are important issues for health care providers to address when discussing treatment options with their patients. Reviewed here are overall patient and health care provider attitudes and perceptions regarding long acting injections and the details of olanzapine long acting injectable, the newest agent, and how it will fit in the marketplace. In addition, efficacy, safety, dosing and use data regarding this newest long acting agent are reviewed and compared to other available long acting agents.


Sign in / Sign up

Export Citation Format

Share Document